Abstract:Objective To evaluate the clinical efficacy of pingyangmycin (PYM) injection on infantile hemangioma located in the parotid gland region. Methods Twelve patients were treated by intralesional injection of PYM. When necessary, the injections were repeated at an interval of one week, but not more than 3-4 sessions within a therapeutic period. Normally, the secondary therapeutic period was performed 1 month later. The general and local adverse responses were recorded and the clinical outcomes were assessed with a follow-up of 1 to 3 years. Results Complete clinical resolutions were achieved in 10 patients. 2 patients received one injection, 3 patients received 2 injections, 3 patients received 3 injections, and 2 patients received 4 injections. The remaining 2 patients with partial resolution received 6 and 7 injections respectively. No clinical recurrence was observed during the follow-up of 1 to 3 years. No ulcerations or postoperative sears in injection regions were presented. The function of facial nerve was remained normality in all patients. The systematic side effects included transient pyrexia and poor appetite appeared in partial patients. No allergy cases were found. Conclusion Treatment of infantile hemangioma located in parotid gland region with PYM injection reveals a high rate of complete clinical resolution, with fair cosmetic results and short treatment time, and it does not damage the facial nerve or form local scar.The treatment time of PYM injection seems to be positively related to size of the lesions.

The Diagnosis and Treatment for Infant Hemangiomas

Effect of Pingyangmycin in Treatment of Infant Oral Hemangioma

Treatment of Infantile Hemangioma in Parotid Gland Region with Pingyangmycin Injection

Controlling therapy with low dose pingyangmycin for infants with parotid gland hemangiomas

Treatment of Proliferative Hemangiomas with High Dose of Systemic Corticosteroid

Pharmacological Therapies For Infantile Hemangiomas: A Clinical Study In 853 Consecutive Patients Using A Standard Treatment Algorithm

Pingyangmycin Sclerotherapy for Infantile Hemangiomas in Oral and Maxillofacial Regions: an Evaluation of 66 Consecutive Patients

A Practical Guide to Treatment of Infantile Hemangiomas of the Head and Neck.

Compare the efficacy of propranolol and Pingyangmycin on infant hemangioma treatment

Injection of Triamcinolone Acetonide Acetate and Pingyangmycin for Infant Hemangioma at Privileged Sites

Treatment of Infantile Hemangioma Located in the Lip with Intralesional Injection of Pingyangmycin

Pharmacotherapy of Infantile Hemangiomas

To Treat the Haemangioma and Vascular Malformation by Surgical Excision Following the Local Injection of Pingyangmycin

Treatment of hemangioma by operation and combined with pingyangmycin injection in children

Surgical Treatment of Parotid Hemangioma in Infants

Progress In The Treatment Of Infantile Hemangioma

Research progress on management of infantile parotid gland hemangiomas

An Experimental Study on the Therapy of Infantile Hemangioma with Recombinant Interferon Γ.

Shift of Treatment Algorithm and Methods for Infantile Hemangiomas

Intralesional Corticosteroid Injections for Infantile Hemangioma

Bleomycin A5 plus dexamethasone for control of growth in infantile parotid hemangiomas.